Cite
HARVARD Citation
Petrak, R. et al. (2021). Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2. Critical care explorations. pp. e0395-. [Online].